Recurrent or Metastatic Head and Neck CancerPhase 1NCT07501650
Ultrasound Microbubble Cavitation + Pembrolizumab
Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
3 Phase 1 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Head and neck3 studies
Recurrent or Metastatic Head and Neck CancerPhase 1NCT07501650
Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 1NCT07455032
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaPhase 1NCT06868433
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer